rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-1-19
|
pubmed:abstractText |
A micro-array analysis using biopsies from patients with EBV-positive undifferentiated nasopharyngeal carcinoma (NPC) and from cancer-free controls revealed down-regulation of tumour suppressor genes (TSG) not previously associated with this disease; one such gene was the ataxia telangiectasia mutated (ATM) gene. Q-PCR confirmed down-regulation of ATM mRNA and ATM protein expression in tumour cells was weak or absent in almost all cases. In NPC cell lines, however, ATM was down-regulated only in the EBV-positive line, C666.1, and in none of five EBV-negative lines. In vitro infection of EBV-negative NPC cell lines with a recombinant EBV was followed by the down-regulation of ATM mRNA and protein, and only EBV-positive cells showed a defective DNA damage response following gamma-irradiation. Our data suggest that loss of ATM function could be an important step in the pathogenesis of NPC, and may have implications for the treatment of this disease.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1096-9896
|
pubmed:author |
pubmed-author:ArrandJohnJ,
pubmed-author:BoseShikhaS,
pubmed-author:BuettnerMaikeM,
pubmed-author:ChukwumaMarilyn BMB,
pubmed-author:DawsonChristopherC,
pubmed-author:FungMatthewM,
pubmed-author:LimPaul V HPV,
pubmed-author:MainaEstherE,
pubmed-author:MorganSusanS,
pubmed-author:MurrayPaul GPG,
pubmed-author:SalehAmyzaA,
pubmed-author:StankovicTatjanaT,
pubmed-author:StarzcynskiJaneJ,
pubmed-author:TeoSoo HwangSH,
pubmed-author:WeiWenbinW,
pubmed-author:WoodmanCiaran B JCB,
pubmed-author:YapLee-FahLF,
pubmed-author:YoungLawrence SLS
|
pubmed:issnType |
Electronic
|
pubmed:volume |
217
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
345-52
|
pubmed:dateRevised |
2011-11-2
|
pubmed:meshHeading |
pubmed-meshheading:19142888-Adenocarcinoma,
pubmed-meshheading:19142888-Case-Control Studies,
pubmed-meshheading:19142888-Cell Cycle Proteins,
pubmed-meshheading:19142888-Cell Line, Tumor,
pubmed-meshheading:19142888-DNA-Binding Proteins,
pubmed-meshheading:19142888-Down-Regulation,
pubmed-meshheading:19142888-Gene Expression Profiling,
pubmed-meshheading:19142888-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:19142888-Gene Expression Regulation, Viral,
pubmed-meshheading:19142888-Herpesvirus 4, Human,
pubmed-meshheading:19142888-Humans,
pubmed-meshheading:19142888-Immunohistochemistry,
pubmed-meshheading:19142888-Nasopharyngeal Neoplasms,
pubmed-meshheading:19142888-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:19142888-Protein-Serine-Threonine Kinases,
pubmed-meshheading:19142888-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:19142888-Tumor Suppressor Proteins,
pubmed-meshheading:19142888-Tumor Virus Infections
|
pubmed:year |
2009
|
pubmed:articleTitle |
The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma.
|
pubmed:affiliation |
Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TT, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|